Finance

Beta
Lists
BEAM:NASDAQ
Beam Therapeutics Inc
$34.69
-0.74%
(-0.26) 1D
Jun 30, 3:13:13 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BEAM...
Open
$34.85
High
$36.06
Low
$33.62
Mkt. cap
3.57B
Avg. vol.
2.23M
Volume
1.06M
52-wk high
$36.88
52-wk low
$15.60
EPS
-$0.64
Beta
2.25
Shares outstanding
102.88M
No. of employees
522
Open
$34.85
High
$36.06
Low
$33.62
Mkt. cap
3.57B
Avg. vol.
2.23M
Volume
1.06M
52-wk high
$36.88
52-wk low
$15.60
EPS
-$0.64
Beta
2.25
Shares outstanding
102.88M
No. of employees
522
News stories
From sources across the web
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc
CEOJohn Evans
Employees522
Founded2017
Headquarters-
SectorBiotechnology
Websitebeamtx.com
Analyst ratings
Based on 11 analysts giving stock ratings to BEAM in the past 3 months
Strong buy
Buy
10
Hold
1
Sell
0
12-month forecast
Based on 11 Wall Street analysts offering 12 month price targets for BEAM in the last 3 months.
Highest
Current $34.69
$80.00 (+130.61%)
Average
$52.91 (+52.52%)
Lowest
$26.00 (-25.05%)
Analyst
Recommendation
Action
Price target
Projected
Date
David Nierengarten
Wedbush
Buy
Maintained
$65.00
+87.4%
06/22/2026
Yanan Zhu
Wells Fargo
Buy
Maintained
$70.00
+101.8%
06/04/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$75.00
+116.2%
05/21/2026
Patrick Trucchio
H.C. Wainwright
Buy
Reiterated
$80.00
+130.6%
05/21/2026
Samantha Semenkow
Citi
Buy
Maintained
$68.00
+96%
05/13/2026
William Pickering
Bernstein
Buy
Reiterated
$39.00
+12.4%
05/13/2026
Alec Stranahan
Bank of America Securities
Buy
Reiterated
$47.00
+35.5%
05/12/2026
Luca Issi
RBC Capital
Hold
Maintained
$26.00
-25.1%
05/08/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$45.00
+29.7%
05/08/2026
Boris Peaker
JonesTrading
Buy
Maintained
$35.00
+0.9%
05/07/2026
Sami Corwin
William Blair
Buy
Reiterated
$32.00
-7.8%
05/07/2026
Soumit Roy
JonesTrading
Buy
Maintained
$35.00
+0.9%
04/06/2026
Brian Cheng
J.P. Morgan
Buy
Maintained
-
-
03/25/2026
William Maughan
Clear Street
Buy
Maintained
$37.00
+6.7%
03/25/2026
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.91 / -$1.01
+9.63%beat
Revenue / Est. (USD)
31.74M / 12.48M
+154.36%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.47M
9.70M
114.11M
31.74M
Cost of goods sold
101.76M
109.77M
99.28M
11.06M
Cost of revenue
101.76M
109.77M
99.28M
11.06M
Research and development expenses
-
-
-
93.47M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.86M
26.74M
32.28M
34.43M
Operating expense
26.86M
26.74M
32.28M
127.90M
Total operating expenses
128.62M
136.51M
131.55M
138.95M
Operating income
-120.15M
-126.81M
-17.44M
-107.22M
Other non operating income
1.15M
8.55M
50.00K
2.50M
EBT including unusual items
-102.29M
-112.73M
244.30M
-94.32M
EBT excluding unusual items
-106.68M
-118.26M
248.39M
-94.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-102.29M
-112.73M
244.30M
-94.32M
Net profit margin
-1,208.26%
-1,162.38%
214.09%
-297.18%
Earnings per share
-1.00
-1.10
2.33
-0.91
Interest and investment income
12.33M
-
10.64M
9.87M
Interest expense
-
-
-
-
Net interest expenses
12.33M
-
10.64M
9.87M
Depreciation and amortization charges
-
-
-
-
EBITDA
-114.61M
-121.25M
-11.78M
-101.61M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer